Efpegerglucagon
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Efpegerglucagon, covering 2025-02-21 to 2025-02-21. Get the full timeline:
Most recent: Clinical Trial Update: HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) [Phase 2]